Summary: In 2013 Pfizer launched the Pfizer Blue Button Project, a first-of-it’s-kind initiative enabling patients who have participated in clinical trials the opportunity to download their individual clinical data. Using the Blue Button standard launched by the White House, patients will be empowered to use the data to improve their overall health and wellness, from sharing with healthcare providers to powering clinical risk assessments. In this show, our host Craig Lipset, Head of Clinical Innovation, R&D, Pfizer speaks to the leaders behind these initiatives to find out why they launched, initial learnings, and where the projects may go if successful. Also joining Craig is Thomas Krohn, Business Lead for the Lilly Clinical Open Innovation Team. Host: Craig Lipset, Head of Clinical Innovation, R&D, Pfizer Guests: Adam Dole, Presidential Innovation Fellow, The White House Thomas Krohn, Business Lead for the Lilly Clinical Open Innovation Team Jennifer Wulff, Director, Clinical Innovation, Pfizer
